Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionCrossmark Global Holdings, Inc.
Latest Disclosed Ownership313,084 shares
Latest Disclosed Value $ 32,144,336
Crossmark Global Holdings, Inc. reports 2.58% increase in ownership of ABL / Abbott Laboratories

On May 11, 2026 - Crossmark Global Holdings, Inc. filed a 13F-HR form disclosing ownership of 313,084 shares of Abbott Laboratories (DE:ABL) valued at $27,808,121 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 305,217 shares of Abbott Laboratories. This represents a change in shares of 2.58% during the quarter. The current value of the position is $23,550,178 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ABBOTT LABS COM 002824100 313,084 7,867 2.58 32,144 -15.94 0.4695
2026-02-03 2025-12-31 13F ABBOTT LABS COM 002824100 305,217 4,444 1.48 38,241 -5.08 0.5455
2025-11-12 2025-09-30 13F ABBOTT LABS COM 002824100 300,773 12,373 4.29 40,286 2.70 0.6034
2025-08-08 2025-06-30 13F ABBOTT LABS COM 002824100 288,400 15,562 5.70 39,225 8.38 0.6334
2025-04-30 2025-03-31 13F ABBOTT LABS COM 002824100 272,838 -66,038 -19.49 36,192 95,139.47 0.6383
2025-01-16 2024-12-31 13F ABBOTT LABS COM 002824100 338,876 610 0.18 38 0.00 0.6988
2024-11-04 2024-09-30 13F ABBOTT LABS COM 002824100 338,266 5,047 1.51 39 11.76 0.6878
2024-07-29 2024-06-30 13F ABBOTT LABS COM 002824100 333,219 1,663 0.50 35 -8.11 0.6618
2024-05-13 2024-03-31 13F ABBOTT LABS COM 002824100 331,556 -16,715 -4.80 38 -2.63 0.7225
2024-02-13 2023-12-31 13F ABBOTT LABS COM 002824100 348,271 27,527 8.58 38 22.58 0.7954
2023-11-08 2023-09-30 13F ABBOTT LABS COM 002824100 320,744 128,779 67.08 31 47.62 0.7094
2023-07-31 2023-06-30 13F ABBOTT LABS COM 002824100 191,965 -93,543 -32.76 22 -25.00 0.4656
2023-05-12 2023-03-31 13F ABBOTT LABS COM 002824100 285,508 6,270 2.25 29 -6.67 0.6803
2023-01-19 2022-12-31 13F ABBOTT LABS COM 002824100 279,238 5,391 1.97 31 -99.89 0.7641
2022-11-01 2022-09-30 13F ABBOTT LABS COM 002824100 273,847 -24,629 -8.25 26,498 -18.29 0.7352
2022-07-29 2022-06-30 13F ABBOTT LABS COM 002824100 298,476 -4,893 -1.61 32,430 -9.68 0.8404
2022-05-11 2022-03-31 13F ABBOTT LABS COM 002824100 303,369 4,941 1.66 35,907 -14.51 0.8007
2022-01-10 2021-12-31 13F ABBOTT LABS COM 002824100 298,428 -22,230 -6.93 42,001 10.88 0.9122
2021-10-21 2021-09-30 13F/A-1 ABBOTT LABS COM 002824100 320,658 -21,872 -6.39 37,879 -4.61 0.8875
2021-10-13 2021-09-30 13F ABBOTT LABS COM 002824100 141,380 -201,150 9,693 1.1092
2021-07-21 2021-06-30 13F ABBOTT LABS COM 002824100 342,530 102,089 42.46 39,710 37.81 0.9338
2021-04-15 2021-03-31 13F ABBOTT LABS COM 002824100 240,441 -18,173 -7.03 28,814 1.76 0.7136
2021-01-14 2020-12-31 13F ABBOTT LABS COM 002824100 258,614 -114,949 -30.77 28,315 -30.35 0.7159
2020-10-08 2020-09-30 13F ABBOTT LABS COM 002824100 373,563 -14,753 -3.80 40,655 14.51 1.1401
2020-08-14 2020-06-30 13F ABBOTT LABS COM 002824100 388,316 -15,622 -3.87 35,503 11.38 1.0354
2020-04-28 2020-03-31 13F ABBOTT LABS COM 002824100 403,938 97,646 31.88 31,875 19.81 1.1406
2020-02-06 2019-12-31 13F ABBOTT LABS COM 002824100 306,292 -6,512 -2.08 26,604 1.65 0.7307
2019-10-09 2019-09-30 13F ABBOTT LABS COM 002824100 312,804 6,975 2.28 26,172 1.76 0.7640
2019-07-09 2019-06-30 13F ABBOTT LABS COM 002824100 305,829 -7,412 -2.37 25,720 2.72 0.7212
2019-05-02 2019-03-31 13F ABBOTT LABS COM 002824100 313,241 -32,390 -9.37 25,040 0.16 0.7108
2019-01-31 2018-12-31 13F ABBOTT LABS COM 002824100 345,631 -7,630 -2.16 25,000 -3.53 0.7749
2018-11-08 2018-09-30 13F/A-1 ABBOTT LABS COM 002824100 353,261 -18,271 -4.92 25,915 14.36 0.6577
2018-11-06 2018-09-30 13F ABBOTT LABS COM 002824100 371,532 0 22,660
2018-07-31 2018-06-30 13F ABBOTT LABS COM 002824100 371,532 -1,518 -0.41 22,660 1.37 0.6078
2018-04-16 2018-03-31 13F ABBOTT LABS COM 002824100 373,050 -7,480 -1.97 22,353 2.93 0.5778
2018-02-05 2017-12-31 13F ABBOTT LABS COM 002824100 380,530 -10,836 -2.77 21,717 3.99 0.5218
2017-10-27 2017-09-30 13F ABBOTT LABS COM 002824100 391,366 0 0.00 20,883 0.00 0.5383
2017-10-25 2016-09-30 13F ABBOTT LABS COM 002824100 391,366 391,366 20,883 0.5383
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.